Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Clinical Gastroenterology and Hepatology(2)
Canadian Journal of Gastroenterology and Hepatology(1)
Hepatitis Monthly(1)
Journal of Clinical Gastroenterology(1)
Área temáticas
Enfermedades(4)
Problemas sociales y servicios a grupos(2)
Farmacología y terapéutica(1)
Medicina forense; incidencia de enfermedades(1)
Medicina y salud(1)
Origen
scopus(5)
Abnormal Liver Tests during Hospitalization Pbkp_redict Mortality in Patients with COVID-19: A Multicenter Study from South America
ArticleAbstract: Background. The role of liver function tests (LFT) as prognostic factors in patients admitted with CPalabras claves:Autores:Balderramo D., Bolomo A., Bombassaro I.Z., Carlino Y., Castillo L.T., Chiesa T., Debes J.D., Diaz-Ferrer J., Enrique Carrera, Jaysoom Abarca, Johana Acuña, Karina Díaz, Manero E., Mattos A.Z., Mulqui V., Plácido-Damián Z., Prieto J.E., Wiltgen D.Fuentes:scopusEarly Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America
OtherAbstract:Palabras claves:Autores:Avendaño K., Balderramo D., Ballerga E.G., Barreyro F.J., Cairo F., Carrilho F.J., Chan A.J., Davalos M.B., Debes J.D., Enrique Carrera, Ferrer J.D., Gonçalves P.T., Hernández N., Hirsch B.S., Idrovo V., Kikuchi L., Mattos A.Z., Paredes S., Prieto J.E., Roberts L.R., Tapias M., Yang J.D.Fuentes:scopusHerbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
ArticleAbstract: Background: Herbal and dietary supplements (HDS) consumption, a growing cause of hepatotoxicity, isPalabras claves:Drug-Induced Liver Injury, Hepatotoxicity, Herbal and Dietary Supplements, Herbal-Induced Liver Injury, Latin America, LATINDILI Network, Liver toxicityAutores:Alvarez-Alvarez I., Anders M., Andrade R.J., Arrese M., Bessone F., Caballano-Infantes E., Cabello M.R., Chiodi D., Enrique Carrera, García-Cortés M., Hernández N., Lizarzabal M.I., Lucena M.I., Medina-Cáliz I., Mendizábal M., Montes P., Niu H., Nunes V., Paraná R., Peralta M., Pinazo J., Ridruejo E., Santos G., Schinoni M.I., Tagle M.Fuentes:scopusPIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings
ArticleAbstract:Palabras claves:HCC, hepatocellular carcinoma, SCORE, SorafenibAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopusSorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis from the South American Liver Research Network
ArticleAbstract: Goals:We aim to describe the efficacy, safety profile, and variables associated with survival in patPalabras claves:hepatocellular carcinoma, Sorafenib, SOUTH AMERICA, SurvivalAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopus